# A retrospective chart review assessing antibiotic treatment of hospitalized patients with discordant Clostridioides difficile assays in an urban hospitalized setting

**Authors:** Clare Stoddart, Irene Kuo, Matthew A. Spence, Tara N. Palmore

PMC · DOI: 10.1017/ash.2024.60 · Antimicrobial Stewardship & Healthcare Epidemiology : ASHE · 2024-04-23

## TL;DR

This study examines how age affects antibiotic treatment decisions in patients with conflicting C. difficile test results in a hospital setting.

## Contribution

The study identifies age as a significant factor in antibiotic prescription decisions following discordant CDI testing.

## Key findings

- Patients aged 65+ years were more likely to receive antibiotics after discordant testing.
- Discordant testing results influenced treatment decisions in hospitalized patients.
- Two-step testing helps avoid over-treatment by improving diagnostic specificity.

## Abstract

Clostridioides difficile infection (CDI) threatens vulnerable populations in health care. Two-step testing improves specificity, avoiding over-treatment. This study analyzed inpatient records to estimate diagnostic outcomes and identify characteristics associated with treatment after discordant testing. Among discordant patients, those aged 65+ years were significantly more likely to be prescribed antibiotics (67% vs 39%).

## Linked entities

- **Diseases:** CDI (MONDO:0015790)
- **Species:** Clostridioides difficile (taxon 1496)

## Full-text entities

- **Diseases:** CDI (MESH:D003015)
- **Species:** Homo sapiens (human, species) [taxon 9606], Clostridioides difficile (species) [taxon 1496]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11036419/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11036419/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC11036419/full.md

---
Source: https://tomesphere.com/paper/PMC11036419